Abstract
A biochip was developed to examine the polymorphisms of genes associated with schizophrenia risk, including DISC1, RELN, ZNF804A, PLXNA2, COMT, SLC18A1, CACNA1C, ANK2, TPH1, PLAA, and SNAP-25. Allele and genotype frequencies of the genes were determined in 198 schizophrenics and 192 healthy subjects from Bashkortostan (ethnic Russians and Tatars). The frequencies of allele A (p = 0.007) and genotype AA (p = 0.002) of the rs2270641 A>C polymorphism of SLC18A1 in the patients with paranoid schizophrenia was lower than in the healthy subjects. The frequency of genotype AA of the rs1800532 C>A polymorphism of TPH1 in the schizophrenics was higher than in the healthy subjects (p = 0.036). Compared with the healthy subjects, the ethnic Tatar patients with paranoid schizophrenia had a lower frequency of allele C of the rs7341475 C>T polymorphism of RELN (p = 0.039) and a higher frequency of genotype AA of the rs1800532 C>A polymorphism of TPH1 (p = 0.019, OR = 2.52, CI 1.18-5.38). The frequency of allele C (p = 0.0001) and genotype GC (p = 0.0001) of the rs1327175 G>C polymorphism of PLXNA2 was elevated in the patients with a family history of paranoid schizophrenia. Based on the results, the SLC18A1, TPH1, and RELN polymorphisms were associated with risk of schizophrenia.
Similar content being viewed by others
Abbreviations
- SNP:
-
single nucleotide polymorphism
- CNV:
-
copy number variation
- DISC1 :
-
disrupted in schizophrenia 1 gene
- RELN:
-
reelin
- ZNF804A:
-
zinc-finger protein 804A
- PLXNA2:
-
plexin A2
- COMT:
-
catechol-O-methyltransferase
- SLC18A1:
-
vesicular monoamine transporter 1
- CACNA1C:
-
voltage-dependent L-type calcium channel α-1C subunit
- ANK3:
-
ankyrin 3
- TPH1:
-
tryptophan hydroxylase 1
- PLAA:
-
phospholipase A2-activating protein
- SNAP-25:
-
synaptosome-associated protein 25
- PCR:
-
polymerase chain reaction
- RFLP:
-
restriction fragment length polymorphism
References
van Os J., Rutten B.P., Poulton R. 2008. Gene-environment interactions in schizophrenia: Review of epidemiological findings and future directions. Schizophr. Bull. 34, 1066–1082.
Golimbet V.E., Koren’ E.V. 2010.Copy number variations in the human genome: a new page in psychiatric genetics. The collaorative project PsychCNVs. Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. 110(1), 107–109.
Golimbet V.E. 2003. Genetics of schizophrenia. Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. 103, 58–67.
Golimbet V.E., Alfimova M.V., Gritsenko I.K., Lezheiko T.V., Lavrushina O.M., Abramova L.I., Kaleda V.G., Barkhatova A.N., Sokolov A.V., Ebstein R.P. 2010. Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects. Neurosci. Behav. Physiol. 40, 461–465.
Straub R.E., Weinberger D.R. 2006. Schizophrenia genes: Famine to feast. Biol. Psychiatry. 60, 81–83.
Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe’er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 460, 753–757.
Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O’Donovan M.C., Sullivan P.F., Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 460, 748–752.
Zainullina A.G., Iurev E.B., Bikbulatova S.R., Khusnutdinova E.K. 2003. Association of the hSERT and SLC6A4 polymorphic markers of the serotonin transporter gene with schizophrenia in different ethnic groups. Mol. Biol. (Moscow). 37, 508–512.
Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O’Donovan M., O’Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. 2008. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4(2), e28.
Saetre P., Agartz I., De Franciscis A., Lundmark P., Djurovic S., Kähler A., Andreassen O.A., Jakobsen K.D., Rasmussen H.B., Werge T., Hall H., Terenius L., Jönsson E.G. 2008. Association between a disrupted-inschizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr. Res. 106, 237–241.
O’Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Möller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nöthen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genet. 40, 1053–1055.
Mah S., Nelson M.R., Delisi L.E., Reneland R.H., Markward N., James M.R., Nyholt D.R., Hayward N., Handoko H., Mowry B., Kammerer S., Braun A. 2006. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol. Psychiatry. 11, 471–478.
Bly M. 2005. Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia. Schizophr. Res. 78, 337–338.
Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O’donovan M.C., Craddock N. 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry. 15, 1016–1022.
Athanasiu L., Mattingsdal M., Kähler A.K., Brown A., Gustafsson O., Agartz I., Giegling I., Muglia P., Cichon S., Rietschel M., Pietiläinen O.P., Peltonen L., Bramon E., Collier D., Clair D.S., Sigurdsson E., Petursson H., Rujescu D., Melle I., Steen V.M., Djurovic S., Andreassen O.A. 2010. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J. Psychiatr. Res. 44, 748–753.
Saetre P., Lundmark P., Wang A., Hansen T., Rasmussen H.B., Djurovic S., Melle I., Andreassen O.A., Werge T., Agartz I., Hall H., Terenius L., Jönsson E.G. 2010. The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: A multi-centre case-control study and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153, 387–396.
Maniatis, T., Fritsch, E.F., Sambrook, J. 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.
Rubina A.Y., Pankov S.V., Dementieva E.I., Penkov D.N., Butygin A.V., Vasiliskov V.A., Chudinov A.V., Mikheikin A.L., Mikhailovich V.M., Mirzabekov A.D. 2004. Hydrogel drop microchips with immobilized DNA: Properties and methods for large-scale production. Anal. Biochem. 325, 92–106.
Gra O., Mityaeva O., Berdichevets I., Kozhekbaeva Z., Fesenko D., Kurbatova O., Goldenkova-Pavlova I., Nasedkina T. 2010. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians. Genet. Test Mol. Biomarkers. 14, 329–342.
Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. 2001. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69, 138–147.
Lin Z., Su Y., Zhang C., Xing M., Ding W., Liao L., Guan Y., Li Z., Cui D. 2013. The interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophrenia. PLoS ONE. 8(9), e74264.
Galaktionova D.Yu., Gra O.A., Nizamutdinov I.I., Shershov V.E., Kuznetsova V.E., Chudinov A.V., Gareeva A.E., Zakirov D.F., Khusnutdinova E.K., Lysov Yu.P., Nasedkina T.V. 2012. An association study of polymorphisms in HTR2A, BDNF, and SLC6A4 genes with paranoid schizophrenia and suicidal behavior. Zh. Nevrol. Psikhiatr. im. S.S. Korsakova. 112, 39–41.
Nizamutdinova I.I., Andreeva T.V., Stepanov V.A., Marusin A.V., Rogaev E.I., Zasedateleva A.S., Nasedkina T.V. 2013. Biochip for determination of genetic markers of sporadic Alzheimer’s disease risk in the Russian Slavic population. Mol. Biol. (Moscow). 6, 827–835.
Badner J.A., Gershon E.S. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry. 7, 405–411.
Tamminga C.A., Holcomb H.H. 2005. Phenotype of schizophrenia: A review and formulation. Mol. Psychiatry. 10, 27–39.
Lohoff F.W., Weller A.E., Bloch P.J., Buono R.J., Doyle G.A., Ferraro T.N., Berrettini W.H. 2008. Association between polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia. Neuropsychobiology. 57, 55–60.
Chen S.F., Chen C.H., Chen J.Y., Wang Y.C., Lai I.C., Liou Y.J., Liao D.L. 2007. Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia. Schizophr. Res. 90, 363–365.
Nielsen D.A., Jenkins G.L., Stefanisko K.M., Jefferson K.K., Goldman D. 1997. Sequence, slice site and population frequency distribution analyses of the polymorphic human tryptophan intron 7. Mol. Brain Res. 45, 145–148.
Ono H., Shirakawa O., Kitamura N., Hashimoto T., Nishiguchi N., Nishimura A., Nushida H., Ueno Y., Maeda K. 2002. Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol. Psychiatry. 7, 1127–1132.
Hong C.J., Tsai S.J., Wang Y.C. 2001. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr. Res. 49, 59–63.
Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277, 39944–39952.
Carboni G., Tueting P., Tremolizzo L., Sugaya I., Davis J., Costa E., Guidotti A. 2004. Enhanced dizocilpine efficacy in heterozygous reelin mice relates to GABA turnover downregulation. Neuropharmacology. 46, 1070–1081.
Fatemi S.H. (ed.) 2008. Reelin Glycoprotein: Structure, Biology and Roles in Health and Disease. New York: Springer.
Tamagnone L., Artigiani S., Chen H., He Z., Ming G.I., Song H., Chedotal A., Winberg M.L., Goodman C.S., Poo M., Tessier-Lavigne M., Comoglio P.M. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 99, 71–80.
Murakami Y., Suto F., Shimizu M., Shinoda T., Kameyama T., Fujisawa H. 2001. Differential expression of plexin-A subfamily members in the mouse nervous system. Dev. Dynam. 220, 246–258.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.Yu. Galaktionova, A.E. Gareeva, E.K. Khusnutdinova, T.V. Nasedkina, 2014, published in Molekulyarnaya Biologiya, 2014, Vol. 48, No. 4, pp. 629–639.
Rights and permissions
About this article
Cite this article
Galaktionova, D.Y., Gareeva, A.E., Khusnutdinova, E.K. et al. Association of SLC18A1, TPH1, and RELN gene polymorphisms with risk of paranoid schizophrenia. Mol Biol 48, 546–555 (2014). https://doi.org/10.1134/S0026893314030042
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893314030042